Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Keshavan, Matcheri S.
Nasrallah, Henry A.
and
Tandon, Rajiv
2011.
Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse.
Schizophrenia Research,
Vol. 127,
Issue. 1-3,
p.
3.
Boutros, Nash
Galderisi, Silvana
Pogarell, Oliver
and
Segmiller, Felix
2011.
Standard Electroencephalography in Clinical Psychiatry.
p.
113.
Réthelyi, János M.
Czobor, Pál
Polgár, Patrícia
Mersich, Beatrix
Bálint, Sára
Jekkel, Éva
Magyar, Krisztina
Mészáros, Ágnes
Fábián, Ágnes
and
Bitter, István
2012.
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 262,
Issue. 2,
p.
107.
Volpe, Umberto
Mucci, Armida
Quarantelli, Mario
Galderisi, Silvana
and
Maj, Mario
2012.
Dorsolateral prefrontal cortex volume in patients with deficit or nondeficit schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 37,
Issue. 2,
p.
264.
Kitis, Omer
Ozalay, Ozgun
Zengin, E. Burcak
Haznedaroglu, Damla
Eker, M. Cagdas
Yalvac, Dilek
Oguz, Kaya
Coburn, Kerry
and
Gonul, Ali Saffet
2012.
Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non‐deficit schizophrenia.
Psychiatry and Clinical Neurosciences,
Vol. 66,
Issue. 1,
p.
34.
Li, Zhe
Zheng, Bo
Deng, Wei
Liu, Xiang
Zheng, Zhong
and
Li, Tao
2013.
Multi‐components of evoked‐brain potentials in deficit and nondeficit schizophrenia.
Asia-Pacific Psychiatry,
Vol. 5,
Issue. 2,
p.
69.
Sans-Sansa, B.
McKenna, P.J.
Canales-Rodríguez, E.J.
Ortiz-Gil, J.
López-Araquistain, L.
Sarró, S.
Dueñas, R.M.
Blanch, J.
Salvador, R.
and
Pomarol-Clotet, E.
2013.
Association of formal thought disorder in schizophrenia with structural brain abnormalities in language-related cortical regions.
Schizophrenia Research,
Vol. 146,
Issue. 1-3,
p.
308.
Lang, F. U.
Kösters, M.
Lang, S.
Becker, T.
and
Jäger, M.
2013.
Psychopathological long‐term outcome of schizophrenia – a review.
Acta Psychiatrica Scandinavica,
Vol. 127,
Issue. 3,
p.
173.
Boutros, Nash N.
2013.
Standard EEG: A Research Roadmap for Neuropsychiatry.
p.
105.
Galderisi, Silvana
Mucci, Armida
Bitter, Istvan
Libiger, Jan
Bucci, Paola
Wolfgang Fleischhacker, W.
Kahn, René S.
and
for the EUFEST Study Group
2013.
Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial.
European Neuropsychopharmacology,
Vol. 23,
Issue. 3,
p.
196.
Galderisi, Silvana
Bucci, Paola
Mucci, Armida
Kirkpatrick, Brian
Pini, Stefano
Rossi, Alessandro
Vita, Antonio
and
Maj, Mario
2013.
Categorical and dimensional approaches to negative symptoms of schizophrenia: Focus on long-term stability and functional outcome.
Schizophrenia Research,
Vol. 147,
Issue. 1,
p.
157.
Lyne, John
Renwick, Laoise
Grant, Tim
Kinsella, Anthony
McCarthy, Patricia
Malone, Kevin
Turner, Niall
O'Callaghan, Eadbhard
and
Clarke, Mary
2013.
Scale for the Assessment of Negative Symptoms structure in first episode psychosis.
Psychiatry Research,
Vol. 210,
Issue. 3,
p.
1191.
Albayrak, Yakup
Ünsal, Cüneyt
Beyazyüz, Murat
Ünal, Ahmet
and
Kuloğlu, Murat
2013.
Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 45,
Issue. ,
p.
144.
Boutros, Nash N.
2013.
Standard EEG: A Research Roadmap for Neuropsychiatry.
p.
105.
Iyo, Masaomi
Tadokoro, Shigenori
Kanahara, Nobuhisa
Hashimoto, Tasuku
Niitsu, Tomihisa
Watanabe, Hiroyuki
and
Hashimoto, Kenji
2013.
Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis.
Journal of Clinical Psychopharmacology,
Vol. 33,
Issue. 3,
p.
398.
Hirjak, Dusan
Wolf, Robert Christian
Koch, Sabine C.
Mehl, Laura
Kelbel, Janna K.
Kubera, Katharina Maria
Traeger, Tanja
Fuchs, Thomas
and
Thomann, Philipp Arthur
2014.
Neurological Abnormalities in Recent-Onset Schizophrenia and Asperger-Syndrome.
Frontiers in Psychiatry,
Vol. 5,
Issue. ,
Carbon, Maren
and
Correll, Christoph U.
2014.
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
CNS Spectrums,
Vol. 19,
Issue. S1,
p.
35.
Kim, Do-Won
Shim, Miseon
Kim, Jeong-In
Im, Chang-Hwan
and
Lee, Seung-Hwan
2014.
Source Activation of P300 Correlates with Negative Symptom Severity in Patients with Schizophrenia.
Brain Topography,
Vol. 27,
Issue. 2,
p.
307.
Kimura, Hiroshi
Kanahara, Nobuhisa
Komatsu, Naoya
Ishige, Minoru
Muneoka, Katsumasa
Yoshimura, Masayuki
Yamanaka, Hiroshi
Suzuki, Tomotaka
Komatsu, Hideki
Sasaki, Tsuyoshi
Hashimoto, Tasuku
Hasegawa, Tadashi
Shiina, Akihiro
Ishikawa, Masatomo
Sekine, Yoshimoto
Shiraishi, Tetsuya
Watanabe, Hiroyuki
Shimizu, Eiji
Hashimoto, Kenji
and
Iyo, Masaomi
2014.
A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
Schizophrenia Research,
Vol. 155,
Issue. 1-3,
p.
52.
Csukly, Gábor
Polgár, Patrícia
Tombor, László
Benkovits, Judit
and
Réthelyi, János
2014.
Theory of mind impairments in patients with deficit schizophrenia.
Comprehensive Psychiatry,
Vol. 55,
Issue. 2,
p.
349.
Comments
No Comments have been published for this article.